medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2019, Number 2

<< Back Next >>

An Med Asoc Med Hosp ABC 2019; 64 (2)

Frequency of hypovitaminosis D in older adults in a preventive medicine Clinic in Mexico City

Ríos ZCA, Calderón-Du PDE, Padilla QMP, Ángeles LAR

Language: Spanish
References: 21
Page: 98-103
PDF size: 190.70 Kb.


ABSTRACT

Introduction: Hypovitaminosis D is a high-prevalent health problem worldwide. Low serum concentrations of 25-hydroxyvitamin D has been associated with cardiovascular diseases and high mortality. Older adults are at greater risk of deficiency. Nonetheless, hypovitaminosis D frequency is unknown in our population, as well as its association with osteopenia and cardiovascular risk. Objective: Examine the frequency of hypovitaminosis D in asymptomatic older adults, the correlation between serum 25-hydroxyvitamin D concentrations and densitometry results, and identify the associations between vitamin D concentration, age, and cardiovascular risk. Material and methods: We evaluated 303 asymptomatic patients older than 55 years recruited from the department of preventive medicine of Centro Médico ABC between 2016 to 2018. Multiple linear regression was used to assess the correlation between serum 25-hydroxyvitamin D and cardiovascular risk (ACC/AHA 2013). Results: Our population had a mean age of 69 ± 8.5 years, 74.5% had hypovitaminosis D in some degree, 35.64% in the range of insufficiency, 38.61% in the deficiency of which, 10.25% had concentrations lower than 10 ng/mL. We observed a positive correlation between T-score and bone mineral density with the logarithmic function of vitamin D3, and a negative correlation between the concentrations of 25-hydroxyvitamin D and cardiovascular risk evaluated by ACC/AHA 2013. Conclusion: Hypovitaminosis D (‹ 30 ng/mL) is common among older adults and, in the presence of osteopenia, it is associated with higher cardiovascular risk.


REFERENCES

  1. Alkhatatbeh M, Abdul-Razzak KK, Khasawneh LQ, Saadeh NA. High prevalence of vitamin d deficiency and correlation of serum vitamin d with cardiovascular risk in patients with metabolic syndrome. Metab Syndr Rel Disord. 2017;15 (5): 213-219.

  2. Holick Mf. Vitamin D deficiency. N Engl J Med. 2007; 357 (3): 266-281.

  3. Holick MF. Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos Int. 1998; 8 (Suppl): S24-29.

  4. Hamid Z, Riggs A, Spencer T, Redman C, Bodenner D. Vitamin D deficiency in residents of academic long care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc. 2007; 8 (2): 71-75.

  5. Nair R, Maseeh A. Vitamin D: the “sunshine” vitamin. J Pharmacol Pharmacother. 2012; 3 (2): 118-126.

  6. Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson- Hughes B, Eisman J et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis Int. 2009; 20 (11): 1807-1820.

  7. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin”. J Clin Endocrinol Metab. 1988; 67 (2): 373-378.

  8. Safarpour M, Reza HS, Mohamadzade M, Bijani A, Fotouhi A. Predictors of incidence of fall in elderly women; a six-month cohort study. Bull Emerg Trauma. 2018; 6 (3): 226-232.

  9. He Y, Timofeeva M, Farrington SM, Vaughan-Shaw P, Svinti V, Walker M et al. Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study. BMC Med. 2018; 16 (1): 142.

  10. T essier AJ, Chevalier S. An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients. 2018; 10 (8): pii: E1099.

  11. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011; 25 (4): 585-591.

  12. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96 (7): 1911-1930.

  13. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. Relationships of Serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009; 94 (4): 1244-1250.

  14. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006; 81 (3): 353-373.

  15. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005; 90 (6): 3215-3224.

  16. F orrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res. 2011; 31 (1): 48-54.

  17. Secretaría de Salud. Encuesta Nacional de Salud y Nutrición 2006. 2006.

  18. López-Bautista F, Posadas-Romero C, Ruiz-Vargas LY, Cardoso-Saldaña G, Juárez-Rojas JG, Medina-Urrutia A et al. Vitamin D deficiency is not associated with fatty liver in a Mexican population. Ann Hepatol. 2018; 17 (3): 419-425.

  19. ¿Qué es la vitamina D? ¿Qué efecto tiene? [Consultado 22 Mayo 2019] Disponible en: https://ods.od.nih.gov/factsheets/ VitaminD-DatosEnEspanol/.

  20. Mandarino N, Júnior F, Salgado J, Lages J, Filho N. Is vitamin D deficiency a new risk factor for cardiovascular disease? Open Cardiovasc Med J. 2015; 9 (1): 40-49.

  21. Al Mheid I, Patel RS, Tangpricha V, Quyyumi AA. Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J. 2013; 34 (48): 3691-3698.




2020     |     www.medigraphic.com